Drug intelligence / Profile preview

Al18F-TCO-BCMAnano

Development stage
Preclinical
Lead developer
First Affiliated Hospital of Jinan University
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Nanobodies (VHH) → Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Al18F-TCO-BCMAnano is a preclinical fluorine-18-labeled nanobody-based radiopharmaceutical designed for positron emission tomography (PET) imaging of multiple myeloma. It consists of a high-affinity nanobody (BCMAnano) targeting B-cell maturation antigen (BCMA), which is conjugated to aluminum fluoride-18 (Al18F) via trans-cyclooctene (TCO) click chemistry. Developed by researchers from the First Affiliated Hospital of Jinan University, the Chinese Academy of Medical Sciences, Peking Union Medical College, and Emory University, Al18F-TCO-BCMAnano exhibits high stability and low bone accumulation in vivo, enabling sensitive and specific visualization of BCMA-expressing multiple myeloma lesions.

Other names
Al 18F-TCO-BCMAnanoAl18F-TCO-BCMAnanoAl-18F-TCO-BCMAnano
02

Targets

BCMA (B-cell maturation antigen)

Beyond the preview

Go deeper on Al18F-TCO-BCMAnano.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Al18F-TCO-BCMAnano.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call